FBLG (FibroBiologics) Notes Receivable: $0.00 Mil (As of Mar. 2026)


FBLG FibroBiologics Inc FBLG
13 GF Score
Price $0.93
! 3 Warning Signs
View Full Analysis

What is FibroBiologics Notes Receivable?

FibroBiologics FBLG +17.31% 13 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates FBLG with a GF Score™ of 13/100. The stock has 3 warning signs investors should review.

FibroBiologics's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

FibroBiologics Notes Receivable Historical Data

* Premium members only.

The historical data trend for FibroBiologics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics Notes Receivable Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

FibroBiologics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FBLG
13GF Score
FibroBiologics Inc FBLG
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FibroBiologics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
FibroBiologics (FBLG) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on FibroBiologics and its competitors.
Is FibroBiologics' Notes Receivable too high?
FibroBiologics' current Notes Receivable is $0.00 Mil. Overall, FibroBiologics has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does FibroBiologics' Notes Receivable compare to CELZ and GLMD?
FibroBiologics' Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on FibroBiologics and its competitors. FibroBiologics's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FibroBiologics stock overvalued right now?
FibroBiologics (FBLG) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. FibroBiologics' overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For FibroBiologics (FBLG), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FibroBiologics Business Description

Address 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
13GF Score

Get the complete analysis for FBLG

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price